From Nasdaq:

The guru fundamental report for JOHNSON & JOHNSON (JNJ) rates it highest with the P/B Growth Investor model. It is a large-cap growth stock in the Biotechnology & Drugs industry with an 88% rating based on the firm’s underlying fundamentals and stock’s valuation. The stock meets most of the strategy’s tests, except for research and development to assets. Partha Mohanram’s research on separating winners from losers among low book-to-market stocks using financial statement analysis has influenced this growth model. Validea is an investment research service that follows the published strategies of investment legends and offers stock analysis and model portfolios.



Read more: Guru Fundamental Report for JNJ